| Year |
Citation |
Score |
| 2016 |
Wang X, Li X, Li J, Hou J, Qu Y, Yu C, He F, Xu W, Wu J. Design, synthesis and preliminary bioactivity evaluations of N(1) -hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors. Chemical Biology & Drug Design. PMID 27416889 DOI: 10.1111/cbdd.12819 |
0.313 |
|
| 2016 |
He L, Liang JH, Wu JZ, Li Y, Qin SC, Miao Y, Wu YJ, Wang Y, Wang L, Fan L, Li JY, Xu W. Low absolute CD4(+) T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 27388165 DOI: 10.1007/s13277-016-5124-9 |
0.317 |
|
| 2016 |
Li F, Wang ZM, Wu JJ, Wang J, Xie SS, Lan JS, Xu W, Kong LY, Wang XB. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 1-13. PMID 27384289 DOI: 10.1080/14756366.2016.1201814 |
0.306 |
|
| 2016 |
Wu J, Xu X, Lee EJ, Shull AY, Pei L, Awan F, Wang X, Choi JH, Deng L, Xin HB, Zhong W, Liang J, Miao Y, Wu Y, Fan L, ... ... Xu W, et al. Phenotypic alteration of CD8+ T cells in chronic lymphocytic leukemia is associated with epigenetic reprogramming. Oncotarget. PMID 27302925 DOI: 10.18632/Oncotarget.9941 |
0.307 |
|
| 2016 |
Jiang Y, Li X, Wang X, Wang Z, Zhang J, Wu J, Xu W. Design, Synthesis, Biological Chracterization of Tamibarotene Analogs as Anticancer Agents. Chemical Biology & Drug Design. PMID 27113097 DOI: 10.1111/cbdd.12778 |
0.309 |
|
| 2016 |
Wang X, Xu W, Fan M, Meng T, Chen X, Jiang Y, Zhu D, Hu W, Gong J, Feng S, Wu J, Li Y. Deoxynivalenol induces apoptosis in PC12 cells via the mitochondrial pathway. Environmental Toxicology and Pharmacology. 43: 193-202. PMID 27017380 DOI: 10.1016/j.etap.2016.03.016 |
0.303 |
|
| 2016 |
Lu TX, Miao Y, Wu JZ, Gong QX, Liang JH, Wang Z, Wang L, Fan L, Hua D, Chen YY, Xu W, Zhang ZH, Li JY. The distinct clinical features and prognosis of the CD10(+)MUM1(+) and CD10(-)Bcl6(-)MUM1(-) diffuse large B-cell lymphoma. Scientific Reports. 6: 20465. PMID 26857366 DOI: 10.1038/srep20465 |
0.326 |
|
| 2015 |
Yang YQ, Liang JH, Wu JZ, Wang L, Qu XY, Cao L, Zhao XL, Huang DP, Fan L, Li JY, Xu W. Elevated absolute monocyte count predicts unfavorable outcomes in patients with angioimmunoblastic T-cell lymphoma. Leukemia Research. PMID 26764222 DOI: 10.1016/j.leukres.2015.12.010 |
0.308 |
|
| 2015 |
Wei L, Huang C, Yang H, Li M, Yang J, Qiao X, Mu L, Xiong F, Wu J, Xu W. A potent anti-inflammatory peptide from the salivary glands of horsefly. Parasites & Vectors. 8: 556. PMID 26496724 DOI: 10.1186/s13071-015-1149-y |
0.384 |
|
| 2015 |
Huang Y, Wu JZ, Li JY, Xu W. Know the enemy as well as the weapons in hand: the aberrant death pathways and therapeutic agents in chronic lymphocytic leukemia. American Journal of Cancer Research. 5: 2361-75. PMID 26396912 |
0.308 |
|
| 2015 |
Fang C, Zhu DX, Wang L, Fan L, Xu J, Wu JZ, Lu TX, Li JY, Wu CP, Xu W. Association between polymorphism of CD20 gene and chronic lymphocytic leukemia in Chinese population. International Journal of Clinical and Experimental Medicine. 8: 11235-43. PMID 26379930 |
0.302 |
|
| 2015 |
Li X, Wu J, Li X, Mu W, Liu X, Jin Y, Xu W, Zhang Y. Development of N-hydroxybenzamide derivatives with indole-containing cap group as histone deacetylases inhibitors. Bioorganic & Medicinal Chemistry. PMID 26349626 DOI: 10.1016/j.bmc.2015.08.040 |
0.305 |
|
| 2015 |
Lu TX, Fan L, Wang L, Wu JZ, Miao KR, Liang JH, Gong QX, Wang Z, Young KH, Xu W, Zhang ZH, Li JY. MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma. Oncotarget. PMID 26158410 DOI: 10.18632/ONCOTARGET.4073 |
0.324 |
|
| Show low-probability matches. |